Key result
The tongue menthol test detected a non-significant decrease in the cold sensation detection threshold after the first oxaliplatin dose, but a significant decrease was observed after repeated doses.
Why the study?
To determine whether the tongue menthol test measuring the cold sensation detection threshold before and after oxaliplatin administration provides an objective evaluation method for oxaliplatin-induced peripheral neuropathy.
Does the tongue menthol test objectively evaluate oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer?
Observational (n=41)
Does the tongue menthol test objectively evaluate oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer?
The tongue menthol test may serve as an objective method to predict the exacerbation of oxaliplatin-induced peripheral neuropathy at an early stage.
Answers are grounded in this paper and cite their sources.
Tongue menthol test detects threshold changes after repeated oxaliplatin doses; hypothesis-generating for objective neuropathy assessment and needs prospective validation.
Objectives: To determine whether the tongue menthol test, which measures the cold sensation detection threshold (CDT) of the tongue, used before and after oxaliplatin administration is an objective evaluation method for oxaliplatin-induced peripheral neuropathy (OPN). Methods: The tongue menthol test was administered to patients both before and after undergoing chemotherapy containing oxaliplatin for colorectal cancer. The tongue menthol test was conducted by applying a menthol solution (a selective agonist of transient receptor potential cation channel subfamily M member 8 [TRPM8]) to the tongue and measuring the CDT. Conclusions: By performing a menthol test in oxaliplatin-treated patients, it may be possible to objectively predict the exacerbation of peripheral neuropathy at an early stage.
No takes yet. Share an insight, caveat, or question.
Cheong et al. (2022) conducted an observational in Colorectal cancer (n=41). Oxaliplatin chemotherapy vs. Pre-administration baseline was evaluated on Cold sensation detection threshold (CDT) after the first administration of oxaliplatin (p=0.24). The tongue menthol test detected a non-significant decrease in the cold sensation detection threshold after the first oxaliplatin dose, but a significant decrease was observed after repeated doses.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: